156 related articles for article (PubMed ID: 15286811)
1. The influence of the human genome on chronic viral hepatitis outcome.
de Andrade DR; de Andrade DR
Rev Inst Med Trop Sao Paulo; 2004; 46(3):119-26. PubMed ID: 15286811
[TBL] [Abstract][Full Text] [Related]
2. Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population.
Kummee P; Tangkijvanich P; Poovorawan Y; Hirankarn N
J Viral Hepat; 2007 Dec; 14(12):841-8. PubMed ID: 18070287
[TBL] [Abstract][Full Text] [Related]
3. Induction of oral immune regulation towards liver-extracted proteins for treatment of chronic HBV and HCV hepatitis: results of a phase I clinical trial.
Israeli E; Safadi R; Melhem A; Pappo O; Shibolet O; Klein A; Hemed N; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Liver Int; 2004 Aug; 24(4):295-307. PubMed ID: 15287852
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B viral factors and clinical outcomes of chronic hepatitis B.
Lin CL; Kao JH
J Biomed Sci; 2008 Mar; 15(2):137-45. PubMed ID: 18058038
[TBL] [Abstract][Full Text] [Related]
5. Dengue and dengue haemorrhagic fever: implications of host genetics.
Chaturvedi U; Nagar R; Shrivastava R
FEMS Immunol Med Microbiol; 2006 Jul; 47(2):155-66. PubMed ID: 16831202
[TBL] [Abstract][Full Text] [Related]
6. The incidence and significance of pattern-recognition receptors in chronic viral hepatitis types B and C in man.
Mozer-Lisewska I; Sikora J; Kowala-Piaskowska A; Kaczmarek M; Dworacki G; Zeromski J
Arch Immunol Ther Exp (Warsz); 2010 Aug; 58(4):295-302. PubMed ID: 20533094
[TBL] [Abstract][Full Text] [Related]
7. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
Chehadeh W; Al-Nakib W
J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
[TBL] [Abstract][Full Text] [Related]
8. The immune response induced by hepatitis B virus principal antigens.
Huang CF; Lin SS; Ho YC; Chen FL; Yang CC
Cell Mol Immunol; 2006 Apr; 3(2):97-106. PubMed ID: 16696896
[TBL] [Abstract][Full Text] [Related]
9. Defining optimal therapeutic outcomes in chronic hepatitis.
Lisker-Melman M; Sayuk GS
Arch Med Res; 2007 Aug; 38(6):652-60. PubMed ID: 17613357
[TBL] [Abstract][Full Text] [Related]
10. [Hepatitis B and C: natural course of disease].
Vince A
Acta Med Croatica; 2005; 59(5):389-92. PubMed ID: 16381232
[TBL] [Abstract][Full Text] [Related]
11. Low-level hepatitis C viremia and humoral immune response to NS4 in chronic hepatitis B virus-hepatitis C virus coinfection.
Chu CM; Sheen IS; Liaw YF
Scand J Gastroenterol; 2004 Aug; 39(8):778-82. PubMed ID: 15513365
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan.
Khan A; Kurbanov F; Tanaka Y; Elkady A; Sugiyama M; Dustov A; Mizokami M
J Med Virol; 2008 Feb; 80(2):268-76. PubMed ID: 18098133
[TBL] [Abstract][Full Text] [Related]
13. Association of TNF-alpha -308 polymorphism with the outcome of hepatitis B virus infection in Turkey.
Basturk B; Karasu Z; Kilic M; Ulukaya S; Boyacioglu S; Oral B
Infect Genet Evol; 2008 Jan; 8(1):20-5. PubMed ID: 17974504
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections.
Oliviero B; Varchetta S; Paudice E; Michelone G; Zaramella M; Mavilio D; De Filippi F; Bruno S; Mondelli MU
Gastroenterology; 2009 Sep; 137(3):1151-60, 1160.e1-7. PubMed ID: 19470388
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and management of chronic viral hepatitis: antigens, antibodies and viral genomes.
Chevaliez S; Pawlotsky JM
Best Pract Res Clin Gastroenterol; 2008; 22(6):1031-48. PubMed ID: 19187865
[TBL] [Abstract][Full Text] [Related]
16. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
Elkady A; Tanaka Y; Kurbanov F; Oynsuren T; Mizokami M
J Gastroenterol Hepatol; 2008 Mar; 23(3):474-81. PubMed ID: 18318825
[TBL] [Abstract][Full Text] [Related]
17. Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients.
Su CW; Huang YH; Huo TI; Shih HH; Sheen IJ; Chen SW; Lee PC; Lee SD; Wu JC
Gastroenterology; 2006 May; 130(6):1625-35. PubMed ID: 16697726
[TBL] [Abstract][Full Text] [Related]
18. Genetics, genomics, and proteomics: implications for the diagnosis and the treatment of chronic hepatitis C.
Asselah T; Bièche I; Paradis V; Bedossa P; Vidaud M; Marcellin P
Semin Liver Dis; 2007 Feb; 27(1):13-27. PubMed ID: 17295174
[TBL] [Abstract][Full Text] [Related]
19. Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms.
Cheong JY; Cho SW; Hwang IL; Yoon SK; Lee JH; Park CS; Lee JE; Hahm KB; Kim JH
J Gastroenterol Hepatol; 2006 Jul; 21(7):1163-9. PubMed ID: 16824070
[TBL] [Abstract][Full Text] [Related]
20. Influence of viral load and genotype in the progression of Hepatitis B-associated liver cirrhosis to hepatocellular carcinoma.
Mahmood S; Niiyama G; Kamei A; Izumi A; Nakata K; Ikeda H; Suehiro M; Kawanaka M; Togawa K; Yamada G
Liver Int; 2005 Apr; 25(2):220-5. PubMed ID: 15780042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
